Posttransplantation Lymphoproliferative Disorder in Lung Transplant Recipients | Zendy

Eli Muchtar | Zendy; Mordechai R. Kramer | Zendy; Liat Vidal | Zendy; Ron Ram | Zendy; Ronit Gurion | Zendy; Yivgenia Rosenblat | Zendy; Ilana Bakal | Zendy; Ofer Shpilberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Posttransplantation Lymphoproliferative Disorder in Lung Transplant Recipients

Author(s) -

Eli Muchtar,

Mordechai R. Kramer,

Liat Vidal,

Ron Ram,

Ronit Gurion,

Yivgenia Rosenblat,

Ilana Bakal,

Ofer Shpilberg

Publication year - 2013

Publication title -

transplantation

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.45

H-Index - 204

eISSN - 1534-6080

pISSN - 0041-1337

DOI - 10.1097/tp.0b013e31829b0718

Subject(s) - medicine , lung transplantation , immunosuppression , transplantation , asymptomatic , lymphoproliferative disorders , lung , post transplant lymphoproliferative disorder , surgery , lymphoma , rituximab

Posttransplantation lymphoproliferative disorder (PTLD) is a well-recognized complication after solid-organ transplantation. Historically, most cases of PTLD among lung transplant recipients occurred within the first year from transplantation and were associated with Epstein-Barr virus (EBV) infection. However, there are increasing reports on a late-onset form of PTLD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research